Monthly Prescribing Reference

Investigational SC Formulation of Ocrelizumab Noninferior to IV Infusion in MS Trial

Credit: Getty Images. The SC formulation is intended to be administered in 10 minutes twice a year. Positive data were announced from a phase 3 trial evaluating an investigational subcutaneous (SC) ...
Monthly Prescribing Reference

Continuous SC Infusion Therapy Bests Oral Levodopa/Carbidopa in Parkinson Trial

Credit: Thinkstock. The randomized, double-blind, double-dummy, active-controlled study compared ABBV-951 via continuous SC infusion to oral levodopa/carbidopa. Positive results were announced from a ...
Post and Courier

New COVID infusion therapy now available at SC hospitals, but supply is tricky

A COVID-19 therapy that might be able to help high-risk patients stay healthy enough to avoid a hospital visit is rolling out at South Carolina hospitals, though the drug is unapproved and its ...
PR Newswire

NeuroDerm Announces Highly Positive Results from the Pivotal Phase III BouNDless Trial Evaluating ND0612 in Parkinson's Disease Patients with Motor Fluctuations

ND0612, a continuous 24 hours/day subcutaneous (SC) infusion of liquid levodopa/carbidopa (LD/CD), showed superior efficacy compared to oral LD/CD for the primary endpoint ("ON" time without ...